Real-time monitoring of human blood-brain barrier disruption - Wikidata - awgldk - TriplyDB

Real-time monitoring of human blood-brain barrier disruption

Real-time monitoring of human blood-brain barrier disruption

http://www.wikidata.org/entity/Q30359368

about

Photodynamic opening of blood-brain barrier.Photodynamic opening of the blood-brain barrier to high weight molecules and liposomes through an optical clearing skull window Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain

P2860

Q46043826-0BDA2B90-6A99-40AB-BEED-17C00D2B18CC Q57493450-5E8235CB-0FCC-497D-88CC-F274D4A163FD Q58698278-D118009B-765C-4891-9949-463B8DB6216A

P2860

Real-time monitoring of human blood-brain barrier disruption

http://www.wikidata.org/entity/Q30359368

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Real-time monitoring of human blood-brain barrier disruption

@ast

Real-time monitoring of human blood-brain barrier disruption

@en

type

label

Real-time monitoring of human blood-brain barrier disruption

@ast

Real-time monitoring of human blood-brain barrier disruption

@en

prefLabel

Real-time monitoring of human blood-brain barrier disruption

@ast

Real-time monitoring of human blood-brain barrier disruption

@en

P1433

Q30359368-965EACC9-E296-497F-99A9-56A8BD8D6AA9

P1476

Q30359368-54395054-06DC-49E2-ABEB-FBE05732EE9A

P2093

Q30359368-09932470-E14C-4AC1-9C3E-C73A48DDF18E

Q30359368-1B4B4102-A4B4-4994-9EF9-D9B89E205C24

Q30359368-2692F24D-7371-4338-8AE9-3C05B20D4C10

Q30359368-3885F3E4-8AA8-4C36-AFFE-05612378AD2A

Q30359368-4699E37E-A2A2-4EC1-9AB0-307643B018B1

Q30359368-71F8B03D-D2BF-40B6-AEC3-30A59375996B

Q30359368-736C4DE8-9A8A-40E3-9BEA-1C8D2162E559

Q30359368-740FAE9E-3B6D-4BBE-9D4D-E9060FEF83AE

Q30359368-85FB8A7F-82BC-4A4B-87E9-B7823685D99E

Q30359368-A4E25844-6364-41EA-B9AD-02780FBFFD12

P2860

Q30359368-0317220A-1669-49D6-A8FA-B7B8739AEF89

Q30359368-031FB1EB-F7C1-49F1-8130-54BE501AB6AF

Q30359368-0593B78B-536A-43A5-9EC4-AC6CAD3AB220

Q30359368-0E17D6E5-0BE9-4EE8-935F-FC0731CD6AF9

Q30359368-143EAE2C-C493-4493-83D0-C25BB61EDBD1

Q30359368-1CFB3130-A42B-4F1B-8DD1-48AE7B69C3E5

Q30359368-2060C651-ABA4-4C1C-881A-615DEB58ECD6

Q30359368-2271557D-09D3-4581-840E-6188BF1307A6

Q30359368-325EBC32-E5C5-438D-B51D-E8BD24411C98

Q30359368-3636A53D-BEE8-4E29-B3C5-498522B6872C

P304

Q30359368-A9913929-D8D2-4229-9229-F1D0A5FAAAA2

P31

Q30359368-CDF20B68-1C58-4D3E-A150-D12B61475394

P356

Q30359368-C981743E-1A42-47FB-B3DA-16293DA06FB2

P407

Q30359368-28FA8D38-9D59-47CA-B7E5-047D986BDE22

P433

Q30359368-65FD7475-EBF8-4DF8-A24A-644341C8D87F

P478

Q30359368-1EC55152-43DF-453B-A985-DD02E11F07C0

P50

Q30359368-0737DA68-B6C0-44C5-8F76-11C214959663

Q30359368-23786A91-8B51-49C4-A405-70BB21FAA500

Q30359368-2B7B2824-4EE6-474A-822E-D40657CE15F9

Q30359368-4B29EFEB-BD37-4C7F-B8D0-E4B1E93BF0B1

P577

Q30359368-BA929D30-54AC-4497-811E-984DD7B72247

P698

Q30359368-8DE415F8-826A-4949-9518-A42823CF99E4

P921

Q30359368-D170CD82-A77A-463C-821B-14FA915CD9BA

P932

Q30359368-A77C24BB-0721-4E88-94F3-3D700EBD8301

P356

JOURNAL.PONE.0174072

P1433

P1476

Real-time monitoring of human blood-brain barrier disruption

@en

P2093

Eila Sonkajärvi

http://www.w3.org/2001/XMLSchema#string

Juha Nikkinen

http://www.w3.org/2001/XMLSchema#string

Matti Isokangas

http://www.w3.org/2001/XMLSchema#string

Osmo Tervonen

http://www.w3.org/2001/XMLSchema#string

Outi Kuittinen

http://www.w3.org/2001/XMLSchema#string

Seppo Alahuhta

http://www.w3.org/2001/XMLSchema#string

Seppo Rytky

http://www.w3.org/2001/XMLSchema#string

Taina Turpeenniemi-Hujanen

http://www.w3.org/2001/XMLSchema#string

Teemu Myllylä

http://www.w3.org/2001/XMLSchema#string

Timo Tuovinen

http://www.w3.org/2001/XMLSchema#string

P2860

Development, maintenance and disruption of the blood-brain barrier

Ultrasound enhanced drug delivery to the brain and central nervous system.

Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium

Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller.

Infraslow oscillations modulate excitability and interictal epileptic activity in the human cortex during sleep.

Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances.

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.

HomER: a review of time-series analysis methods for near-infrared spectroscopy of the brain.

Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity.

Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.

P304

e0174072

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0174072

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Jukka Kortelainen

Tuija Keinänen

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28319185

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

5358768

http://www.w3.org/2001/XMLSchema#string